CI & Patent News: 08/01/2011

1) Dr Reddy’s ties up with UK-based research organisation Argenta:

“… In a statement, John Montana, managing director of Argenta, said the company would work with Dr Reddy’s to identify “novel and differentiated drug candidates for multiple targets meeting unmet clinical needs in pain and inflammation”…..”

2) Request for reexamination for Liponavir/Ritonavir is filed by public patent foundation (Published in last week journal); Patent: 6,703,403; Re examination Application No: 95/000,569; Patentee: Abbott (PUBPAT)

3) NextWave Pharmaceuticals Announces Launch of NEXICLON™ XR – First Extended-Release, Once-Daily Clonidine Oral Suspension and Tablet

4) Aurobindo, Wyeth Settle Spat Over Generic Effexor (law360)

5) US Litigations recently filed complaints

1) Pfizer Inc. et al v. Sandoz Inc (Lyrica Oral solution; Vfend Voriconazole injection); Patents involved in suit 5,364,938 & 6,632,803 (will be updated); View at RFC

2) Alaven Pharmaceutical, LLC v. Seton Pharmaceuticals, LLC (probably Metoclopramide injection) View on RFC

3) APP Pharmaceuticals, LLC v. Navinta LLC (Ropivacaine HCL Injection); Patents in suit 5,670,524  and 5,834,489 View on PriorSmart

4) Aventis Pharma S.A. et. al. v. Accord Healthcare Inc. (Product: Docetaxel Injection); Patents in suit: 5,714,512 and 5,750,561; View on PriorSmart

5) Pronova BioPharma Norge AS v. Apotex Corp (Product: Lovaza; Capsule oral); Patents in suit: 7,732,488; View on PriorSmart

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news, Patent case. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s